Laird Norton Tyee Trust »

Inhibrx Biosciences shares owned by Laird Norton Tyee Trust

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Laird Norton Tyee Trust from 13F filings

Historical chart of Laird Norton Tyee Trust investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Laird Norton Tyee Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Laird Norton Tyee Trust

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 40k 79.00

More positions owned by Laird Norton Tyee Trust

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Laird Norton Tyee Trust

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
State Street Corporation
Millennium Management
Healthcare Of Ontario Pension Plan Trust Fund
Partner Fund Management
Geode Capital Management

View all funds holding Inhibrx Biosciences